Prophylactic approach for asymptomatic post-menopausal women: Osteoporosis

Maturitas

Volumn 52, Issue SUPPL. 1, 2005, Pages 38-45

  Quereda, F ^a,f   Mendoza, N ^b   Olalla, M A ^c   Baro F ^d   Duran M ^e  

^a HOSPITAL UNIVERSITARIO DE SAN JUAN   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^c Virgen de la Victoria Clinic Hospital   (Spain)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^e HOSPITAL CLÍNIC   (Spain)

^f MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

Author keywords

Fracture risk; Osteoporosis; Post menopausal asymptomatic women; Prevention

Indexed keywords

BONE FRAGILITY; BONE TURNOVER; COMMUNITY; COST BENEFIT ANALYSIS; DECISION MAKING; EVOLUTION; FRACTURE; FRAGILITY FRACTURE; HEALTH CARE; HUMAN; MEDICAL LITERATURE; MEDICAL PROFESSION; OSTEOLYSIS; OSTEOPOROSIS; PATHOLOGY; POSTMENOPAUSE; PRACTICE GUIDELINE; PROPHYLAXIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; VASOMOTOR REFLEX;

EID: 27744497230     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2005.06.016     Document Type: Article

References (55)

1. J.M. Wilson, and Y.G. Jungner Principles and practice of mass screening for disease Bol Oficina Sanit Panam 65 1968 281 393
2. J.A. Kanis, P. Delmas, P. Burckhardt, C. Cooper, and D. Torgerson Guidelines for diagnosis and management of osteoporosis. The European Foundation For Osteoporosis and Bone Disease Osteoporos Int 7 1997 390 406
3. T.W. O'Neill, D. Felsenberg, J. Varlow, C. Cooper, J.A. Kanis, and A.J. Silman The prevalence of vertebral deformity in European men and women: the European vertebral osteoporosis study J Bone Miner Res 11 1996 1010 1018
4. M. Diaz Curiel, J.L. Carrasco de la Pena, J. Honorato Perez, R. Perez Cano, A. Rapado, and I. Ruiz Martinez Study of bone mineral density in lumbar spine and femoral neck in a Spanish population. Multicentre research project on osteoporosis Osteoporos Int 7 1997 59 64
5. M. Diaz Curiel, J.J. Garcia, J.L. Carrasco, J. Honorato, R. Perez Cano, and A. Rapado Prevalence of osteoporosis assessed by densitometry in the Spanish female population Med Clin (Barc) 116 2001 86 88
6. A. Izquierdo, P. Viladiu, J. Borras, J. Galceran, J.M. Borras, and J. Dorca The risk of breast cancer in Catalonia Med Clin (Barc) 107 1996 410 413
7. I. Hallberg, A.M. Rosenqvist, L. Kartous, O. Lofman, O. Wahlstrom, and G. Toss Health-related quality of life after osteoporotic fractures Osteoporos Int 15 2004 834 841
8. E. Romagnoli, V. Carnevale, I. Nofroni, E. D'Erasmo, F. Paglia, and S. De Geronimo Quality of life in ambulatory post-menopausal women: the impact of reduced bone mineral density and sub-clinical vertebral fractures Osteoporos Int 15 2004 975 980
9. S.R. Cummings, and L.J. Melton Epidemiology and outcomes of osteoporotic fractures Lancet 359 2002 1761 1767
10. D.M. Kado, T. Duong, K.L. Stone, K.E. Ensrud, M.C. Nevitt, and G.A. Greendale Incident vertebral fractures and mortality in older women: a prospective study Osteoporos Int 14 2003 589 594
11. D.A. Doherty, K.M. Sanders, M.A. Kotowicz, and R.L. Prince Lifetime and five-year age-specific risks of first and subsequent osteoporotic fractures in post-menopausal women Osteoporos Int 12 2001 16 23
12. T.D. Spector, and E.C. Huskisson A rational approach to the prevention and treatment of post-menopausal osteoporosis Drugs 37 1989 205 211
13. F. Richy, O. Ethgen, O. Bruyere, A. Mawet, and J.Y. Reginster Primary prevention of osteoporosis: mass screening scenario or pre-screening with questionnaires? An economic perspective J Bone Miner Res 19 2004 1955 1960
14. D. Rodriguez, C. Aguilera, A. Vallano, and C. Carbonell Advances and controversies in the drug treatment of osteoporosis Aten Primaria 34 2004 202 205
15. A. Cranney, D. Coyle, V. Welch, K. Lee, and P. Tugwell Current controversies in cost effectiveness analysis of osteoporosis therapies J Rheumatol 26 1999 2300 2302
16. L.G. Raisz, and LP. Weicker Jr. Screening for osteoporosis: a clinical, social, and economic dilemma Mayo Clin Proc 75 2000 885 887
17. S. Chakravarti, W.P. Collins, M.H. Thom, and J.W. Studd Relation between plasma hormone profiles, symptoms, and response to oestrogen treatment in women approaching the menopause Br Med J 1 1979 983 985
18. F. Pansini, P. Albertazzi, G. Bonaccorsi, M. Calisesi, C. Campobasso, and L. Zanotti The menopausal transition: a dynamic approach to the pathogenesis of neuro-vegetative complaints Eur J Obstet Gynecol Reprod Biol 57 1994 103 109
19. J.D. Hutton, H.S. Jacobs, M.A. Murray, and V.H. James Relation between plasma oestrone and oestradiol and climacteric symptoms Lancet 1 1978 678 681
20. C.E. James, A.J. Breeson, G. Kovacs, J.G. Hill, C. Grant, and K.M. Allen The symptomatology of the climacteric in relation to hormonal and cytological factors Br J Obstet Gynaecol 91 1984 56 62
21. W.H. Utian Plasma-oestrogen and climacteric symptoms Lancet 1 1978 1099 1100
22. P.B. Rapuri, J.C. Gallagher, and G. Haynatzki Endogenous levels of serum estradiol and sex hormone binding globulin determine bone mineral density, bone remodelling, the rate of bone loss, and response to treatment with oestrogen in elderly women J Clin Endocrinol Metab 89 2004 4954 4962
23. J.P. Levine Long-term oestrogen and hormone replacement therapy for the prevention and treatment of osteoporosis Curr Women's Health Rep 3 2003 181 186
24. J. Poortman, J.H. Thijssen, and F. de Waard Plasma oestrone, oestradiol and androstenedione levels in post-menopausal women: relation to body weight and height Maturitas 3 1981 65 71
25. J. Jensen, B.J. Riis, L. Hummer, and C. Christiansen The effects of age and body composition on circulating serum oestrogens and androstenedione after the menopause Br J Obstet Gynaecol 92 1985 260 265
26. J.A. Cauley, J.P. Gutai, L.H. Kuller, D. LeDonne, and J.G. Powell The epidemiology of serum sex hormones in post-menopausal women Am J Epidemiol 129 1989 1120 1131
27. J.A. Cauley, J.P. Gutai, L.H. Kuller, J. Scott, and M.C. Nevitt Black-white differences in serum sex hormones and bone mineral density Am J Epidemiol 139 1994 1035 1046
28. T.J. Key, P.N. Appleby, G.K. Reeves, A. Roddam, J.F. Dorgan, and C. Longcope Body mass index, serum sex hormones, and breast cancer risk in post-menopausal women J Natl Cancer Inst 95 2003 1218 1226 Notes: Corporate Name: Endogenous Hormones Breast Cancer Collaborative Group
29. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy, March 7-29, 2000: highlights of the conference. South Med J 2001; 94: 569-73.
30. C. Marwick Consensus panel considers osteoporosis JAMA 283 2000 2093 2095
31. L.A. Honkanen, B.R. Schackman, A.I. Mushlin, and M.S. Lachs A cost-benefit analysis of external hip protectors in the nursing home setting J Am Geriatr Soc 53 2 2005 190 197
32. Y.F. Birks, J. Porthouse, and C. Addie Primary Care Hip Protector Trial Group. Randomised controlled trial of hip protectors among women living in the community Osteoporos Int 15 9 2004 701 706
33. H.G. Ahlborg, O. Johnell, B.E. Nilsson, S. Jeppsson, G. Rannevik, and M.K. Karlsson Bone loss in relation to menopause: a prospective study during 16 years Bone 28 2001 327 331
34. A. Cranney, G. Guyatt, L. Griffith, G. Wells, P. Tugwell, and C. Rosen Meta-analyses of therapies for post-menopausal osteoporosis. IX: summary of meta-analyses of therapies for post-menopausal osteoporosis Endocr Rev 23 2002 570 578 Notes: Corporate Name: Osteoporosis Methodology Group and The Osteoporosis Research Advisory Group
35. Management of post-menopausal osteoporosis: position statement of the North American Menopause Society. Menopause 2002; 9: 84-101. Notes: Corporate Name: North American Menopause Society.
36. J.A. Kanis, and C.C. Gluer An update on the diagnosis and assessment of osteoporosis with densitometry. Committee of Scientific Advisors, International Osteoporosis Foundation Osteoporos Int 11 2000 192 202
37. J.L. Reginster Harmonization of clinical practice guidelines for the prevention and treatment of osteoporosis and osteopenia in Europe: a difficult challenge Calcif Tissue Int 59 1996 24 29
38. O. Johnell Clinical usefulness of bone mineral density and the health economy consequences of osteoporosis Horm Res 54 Suppl. 1 2000 64 67
39. N. Zethraeus, W. Ben Sedrine, F. Caulin, S. Corcaud, H.J. Gathon, and M. Haim Models for assessing the cost-effectiveness of the treatment and prevention of osteoporosis Osteoporos Int 13 2002 841 857
40. J.A. Kanis, and B. Jonsson Economic evaluation of interventions for osteoporosis Osteoporos Int 13 2002 765 767
41. P.D. Delmas, R. Rizzoli, C. Cooper, and J.Y. Reginster Treatment of patients with post-menopausal osteoporosis is worthwhile. The position of the International Osteoporosis Foundation Osteoporos Int 16 1 2005 1 5
42. J.A. Kanis, H. Johansson, A. Oden, O. Johnell, C. De Laet, and J.A. Eisman A family history of fracture and fracture risk: a meta-analysis Bone 35 2004 1029 1037
43. J.A. Kanis, O. Johnell, A. Oden, H. Johansson, C. De Laet, and J.A. Eisman Smoking and fracture risk: a meta-analysis Osteoporos Int 16 2 2005 155 162
44. O. Johnell, J.A. Kanis, D.M. Black, A. Balogh, G. Poor, and S. Sarkar Associations between baseline risk factors and vertebral fracture risk in the multiple outcomes of raloxifene evaluation (MORE) study J Bone Miner Res 19 2004 764 772
45. O. Johnell, J.A. Kanis, A. Oden, I. Sernbo, I. Redlund-Johnell, and C. Petterson Fracture risk following an osteoporotic fracture Osteoporos Int 15 2004 175 179
46. S.R. Cummings, M.C. Nevitt, W.S. Browner, K. Stone, K.M. Fox, and K.E. Ensrud Study of Osteoporotic Fractures Research Group. Risk factors for hip fracture in white women N Engl J Med 332 1995 767 773
47. N.B. Watts, C. Cooper, R. Lindsay, R. Eastell, M.D. Manhart, and I.P. Barton Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate: greater increases in bone mineral density do not relate to greater decreases in fracture risk J Clin Densitom 7 2004 255 261
48. P. Garnero, E. Sornay-Rendu, B. Claustrat, and P.D. Delmas Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in post-menopausal women: the OFELY study J Bone Miner Res 15 2000 1526 1536
49. M.A. Hansen Assessment of age and risk factors on bone density and bone turnover in healthy pre-menopausal women Osteoporos Int 4 1994 123 128
50. O. Johnell, A. Oden, C. De Laet, P. Garnero, P.D. Delmas, and J.A. Kanis Biochemical indices of bone turnover and the assessment of fracture probability Osteoporos Int 13 2002 523 526
51. J.Y. Reginster, R. Deroisy, J. Collette, A. Albert, and B. Zegels Prediction of bone loss rate in healthy post-menopausal women Calcif Tissue Int 60 1997 261 264
52. D.M. Black, M. Steinbuch, L. Palermo, P. Dargent-Molina, R. Lindsay, and M.S. Hoseyni An assessment tool for predicting fracture risk in post-menopausal women Osteoporos Int 12 2001 519 528
53. P.D. Miller, E.S. Siris, E. Barrett-Connor, K.G. Faulkner, L.E. Wehren, and T.A. Abbott Prediction of fracture risk in post-menopausal white women with peripheral bone densitometry: evidence from the national osteoporosis risk assessment J Bone Miner Res 17 2002 2222 2230
54. E.S. Siris, Y.T. Chen, T.A. Abbott, E. Barrett-Connor, P.D. Miller, and L.E. Wehren Bone mineral density thresholds for pharmacological intervention to prevent fractures Arch Intern Med 164 2004 1108 1112
55. P.D. Miller, S. Barlas, S.K. Brenneman, T.A. Abbott, Y.T. Chen, and E. Barrett-Connor An approach to identifying osteopenic women at increased short-term risk of fracture Arch Intern Med 164 2004 1113 1120